Kissei Pharmaceutical Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1946-08-09
- Employees
- 1.7K
- Market Cap
- -
- Website
- http://www.kissei.co.jp
Clinical Trials
77
Active:1
Completed:63
Trial Phases
5 Phases
Phase 1:5
Phase 2:27
Phase 3:29
+2 more phases
Drug Approvals
11
NMPA:10
PHILIPPINES:1
Drug Approvals
Mitiglinide Calcium Tablets
- Product Name
- 快如妥
- Approval Number
- 国药准字HJ20140874
- Approval Date
- Sep 22, 2023
NMPA
Mitiglinide Calcium Tablets
- Product Name
- 快如妥
- Approval Number
- 国药准字HJ20140877
- Approval Date
- Sep 22, 2023
NMPA
Mitiglinide Calcium Tablets
- Product Name
- 快如妥
- Approval Number
- 国药准字HJ20140875
- Approval Date
- Sep 22, 2023
NMPA
Mitiglinide Calcium Tablets
- Product Name
- 快如妥
- Approval Number
- 国药准字HJ20140876
- Approval Date
- Sep 22, 2023
NMPA
Clinical Trials
Distribution across different clinical trial phases (65 trials with phase data)• Click on a phase to view related trials
Phase 3
29 (44.6%)Phase 2
27 (41.5%)Phase 1
5 (7.7%)Not Applicable
3 (4.6%)Phase 4
1 (1.5%)Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
Not Applicable
Recruiting
- Conditions
- Spinocerebellar Degeneration
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 142
- Registration Number
- NCT07040137
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
A Clinical Study of KLH-2109 in Patients With Endometriosis
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 288
- Registration Number
- NCT07015268
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 149
- Registration Number
- NCT06757257
- Locations
- 🇯🇵
Research site, Tokyo And Japanese Other Cities, Japan
Special Drug Use-results Survey for Long-term Use（Avacopan）
Recruiting
- Conditions
- Microscopic Polyangiitis (MPA)Granulomatosis With Polyangiitis (GPA)
- Interventions
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT06758271
- Locations
- 🇯🇵
Research site, Multiple Locations, Japan
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06722729
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
No news found